MYCN and neuroblastoma: Although numerous genetic abnormalities, such as gain of chromosome regions 1q and 17q, MYCN amplification, and loss of heterozygosity at chromosome regions 1p, 3p, and 11q, have been proposed as indicators of poor prognosis3, the mechanisms essential for the aggressiveness and progression of NB still warrant further investigation to ameliorate the outcome of patients.